Rawat Mohit Insider Trades

Insider Trading History

Track insider trading activity for Rawat Mohit. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President & CBO
Holding Value $0 0 shares
Last Trade
Jun 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$18.8M 873,399 shares
$21.55
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President & CBO
Holding Value $2.92M 135,500 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 135,500 shares
$8.44
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President & CBO
Holding Value $277k 12,843 shares
Last Trade
Aug 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.3k 12,843 shares
$2.98
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President And CBO
Holding Value $6.47M 300,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 300,000 shares
$3.75
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President And CBO
Holding Value $1.68M 77,900 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$600k 77,900 shares
$7.70
$21.55
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
President And CBO
Holding Value $5.54M 257,000 shares
Last Trade
Sep 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 257,000 shares
$8.26
$21.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up